Showing 8561-8570 of 19297 results for "".
- New Target for Treating Diabetic Cardiomyopathy Identifiedhttps://reachmd.com/news/new-target-for-treating-diabetic-cardiomyopathy-identified/2468762/Advances in understanding diabetic cardiomyopathy have revealed a potential therapeutic target for a disease that currently has no specific treatments. Diabetic cardiomyopathy, a progressive heart condition that is independent of hypertension or other cardiovascular disorders, is one of th
- EMA Validates Bristol Myers Squibb’s Type II Variation Application for Opdivo Plus Yervoy for First-Line Treatment of Unresectable or Advanced HCChttps://reachmd.com/news/ema-validates-bristol-myers-squibbs-type-ii-variation-application-for-opdivo-plus-yervoy-for-first-line-treatment-of-unresectable-or-advanced-hcc/2467580/Bristol Myers Squibb announced that the European Medicines Agency (EMA) validated its Type II variation application for Opdivo (nivolumab) plus Yervoy (ipilimumab) a
- Innovative Approaches to Reversing Age-Related Vision Losshttps://reachmd.com/news/innovative-approaches-to-reversing-age-related-vision-loss/2483545/The promise of lipid restoration strategies to address age-related visual decline has garnered attention, with early-stage research suggesting retinal lipid modulation may improv
- Gene Therapy and Systemic Interventions in Diabetic Eye Diseasehttps://reachmd.com/news/gene-therapy-and-systemic-interventions-in-diabetic-eye-disease/2474557/Diabetic retinopathy and macular edema remain leading causes of vision impairment among individuals with diabetes, presenting significant challenges in ophthalmic care. Emerging gene therapy techniques are being explored to deliver anti-angiogenic proteins that inhibit vascular endothel
- Evaluating the Efficacy of Medical Apps for Diabetes and Heart Disease: Insights from Recent Researchhttps://reachmd.com/news/evaluating-the-efficacy-of-medical-apps-for-diabetes-and-heart-disease-insights-from-recent-research/2471234/Recent research led by the Technical University of Munich questions the true efficacy of telemedicine and exercise apps for managing type 2 diabetes and coronary heart disease, calling for a reevaluation of treatment priorities in patient care.
- Study: Dermabrasion Trials Rarely Report Race or Skin Typehttps://reachmd.com/news/study-dermabrasion-trials-rarely-report-race-or-skin-type/2474005/Most clinical trials studying dermabrasion have failed to report racial or skin-type demographics, according to a new systematic review. "Clinical trials that are racially homogenous or do not report race limit the generalizab
- Frailty, Not Just Surgery Type, Is a Major Determinant of Postoperative Outcomes in Older Adultshttps://reachmd.com/news/frailty-not-just-surgery-type-is-a-major-determinant-of-postoperative-outcomes-in-older-adults/2467024/A new study of Medicare beneficiaries aged 65 and older undergoing non-cardiac surgeries has revealed that frailty is a significant predictor of postoperative outcomes, regardless of the type of surgery performed. Frail patients faced notably hi
- Emerging Trends and Clinical Impacts of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Diabetes and Kidney Carehttps://reachmd.com/news/emerging-trends-and-clinical-impacts-of-sglt2-inhibitors-and-glp-1-receptor-agonists-in-diabetes-and-kidney-care/2484823/SGLT2 inhibitors and GLP-1 receptor agonists have reshaped cardiorenal management for patients with chronic kidney disease (CKD) and type 2 diabetes; recent data confirm this therapeutic shift is now clinically consequential. Prescriptions rose steadily between 2012 and 2023, aligning with
- Study Finds Stuttering in Adolescence Linked to Higher Risk of Prediabetes and Type 2 Diabetes in Early Adulthoodhttps://reachmd.com/news/study-finds-stuttering-in-adolescence-linked-to-higher-risk-of-prediabetes-and-type-2-diabetes-in-early-adulthood/2467372/The study found an association between stuttering in adolescence and a higher risk of dysglycemia in early adulthood for women and men. Screening and targeted prevention may be beneficial in this population, especially women. Stuttering is a speech disorder characterized by interruption
- The Consumption of Certain Food Additive Emulsifiers Could Be Associated with the Risk of Developing Type 2 Diabeteshttps://reachmd.com/news/the-consumption-of-certain-food-additive-emulsifiers-could-be-associated-with-the-risk-of-developing-type-2-diabetes/2462841/by INRAE - National Research Institute for Agriculture, Food and Environment